HIV research studies are crucial in the fight against AIDS. It is through research that new medications and treatments are developed.
How can I help?
Pitt's HIV research studies need all types of people? people who have HIV and those who do not; people who are experiencing complications and those who feel well; people who currently are on HIV medications and those who are not. Every study is not appropriate for every person, but our HIV research recruiters and clinicians can let you know if there is a study that is right for you.
What can I expect?
A clinical trial is a planned investigation that involves volunteers and is designed to determine the most appropriate treatment for future patients. Some trials test how well an intervention works, others look for new methods of screening, prevention, diagnosis, or therapy. The specifics of each study are different. Some studies require blood draws for lab work, some require medications, others do not require these things. The research study team will do its best to match you with a study for which you are eligible and with which you are comfortable.
Research doctors around the world are interested in finding safe treatments that may allow people with HIV to stay healthy
without taking daily medication. These treatments are aimed at reducing the amount of HIV in the body, improving the body's immunity against the HIV virus, or both. Individuals with HIV who are otherwise healthy may be eligible to participate in studies that will evaluate new treatments such as vaccines, antibodies, and others.
Jamie Fullerton
University of Pittsburgh Department of Medicine
Division of Infectious Diseases, HIV/AIDS Program
3520 Fifth Avenue, Suite 510
Pittsburgh, PA 15213
T: 412-383-1044/ C: 412-956-9686
F: 412-383-2900 E: idelucaj@upmc.edu
Most of the study visits occur at the PACT/ CCID Clinic on the 7th floor of the Falk Building